The ongoing COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection has been devastating for all people worldwide. The SARS-CoV-2 helicase (nonstructural protein 13, NSP13) is essential for coronavirus replication. It is capable of separating double-stranded RNA (dsRNA). Scientists have attempted to study the key sites where the helicase binds template RNA, providing critical structural information for developing inhibitors against the helicase. Thus, the identification of small molecules that specifically target the replication apparatus has shown the greatest potential for antiviral drug discovery.
In order to develop the SARS-CoV-2 helicase targeted library, BOC Sciences is focused on offering compounds with predicted activity against this vital protein.
Figure 1. Virion structure and genomic organization of SARS-CoV-2. (Chiem, K.; et al. 2020)
Table1. Physicochemical parameters for the BOC Sciences SARS-CoV-2 Helicase Targeted Library
Parameter | Value |
MW | 396.4 |
ClogP | 3.4 |
SlogP | -5.4 |
Number of Rotatable Bonds | 4.4 |
Number of H Donors | 0.9 |
Number of H Acceptors | 4.9 |
Number of Halogen Atoms | 0.4 |
Number of Rings | 4 |
Compounds with ‘undesirable’ functionalities | Removed |
Number of Rings | 0-5 |
Number of Aromatic Rings | 0-175 |
Fraction of SP3-Hybridized Carbons | 0.2 |
PSA | 88 |
BOC Sciences provides professional, rapid and high-quality services of SARS-CoV-2 Helicase Targeted Library design at competitive prices for global customers. Personalized and customized services of SARS-CoV-2 Helicase Targeted Library design can satisfy any innovative scientific study demands. Our clients have direct access to our staff and prompt feedback to their inquiries. If you are interested in our services, please contact us immediately!
Reference
BOC Sciences has rich experience in working with global customers in custom library synthesis of compounds and generating small to medium-sized libraries of target compounds. Our knowledge in generating a large number of target molecules in a remarkably shorter time enables quick biological screenings for affinities. With the target properties in mind, we deliver target molecules, by applying our extensive knowledge in drug discovery.